Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery Ricardo L Levin, MD, Marcela A Degrange, MD, Gustavo F Bruno,

Slides:

Advertisements

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Advertisements

POSSUM scoring system as an instrument of audit in lung resection surgery Alessandro Brunelli, MD, Aroldo Fianchini, MD, Rosaria Gesuita, MS, Flavia Carle,

Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,

New-onset sustained ventricular tachycardia and fibrillation early after cardiac operations John A Yeung-Lai-Wah, MBChB, Anzhen Qi, MD, Elizabeth McNeill,

Lily E. Johnston, MD, MPH, Jennifer L. Kirby, MD, PhD, Emily A

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery Ming Liu, MS, MA, Charlotte M. Druschel,

Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations W. Brent Keeling, MD, Jose Binongo, PhD, Eric.

Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival J. Hunter Mehaffey, MD, Lily E. Johnston, MD,

Immunology and failure of valved allografts in children

CTSNet: a unique educational vehicle

Michael L. Bailey, MBBS, Sven M. Richter, MD, Daniel V

What is the marginal cost for marginal risk in cardiac surgery?

Heterotopic pancreas of the esophagus masquerading as Boerhaave’s syndrome R.Thomas Temes, MD, Michael J Menen, MD, Michael S Davis, MD, Stuart B Pett,

Coronary artery operation in patients after breast cancer therapy

François Dagenais, MD, L.Conrad Pelletier, MD, Michel Carrier, MD

Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis

Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass–induced injury Maurice Beghetti, MD, Philip E Silkoff, Marlova Caramori, MD,

Morbidity and mortality after 94 extrapleural pneumonectomies for empyema Yuji Shiraishi, MD, Yutsuki Nakajima, MD, Akira Koyama, MD, Keiichiro Takasuna,

Public policy and the practicing physician

12-Month Outcome After Cardiac Surgery: Prediction by Troponin T in Combination With the European System for Cardiac Operative Risk Evaluation Giovanna.

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Who Do You Say You Are? The Annals of Thoracic Surgery

Transthoracic Repair of Slipped Nissen Fundoplications: Technique and Results Ruchir Puri, MD, Adam M. Cline, MD, MS, Daniel T. DeArmond, MD, Scott B.

Damien J. LaPar, MD, MS, James M. Isbell, MD, MSCI, Daniel P

Infected aneurysm of the thoracic aorta

Heparin-induced thrombocytopenia and cardiac surgery

Use of Amiodarone After Major Lung Resection

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Kuthan Kavakli, MD, Deniz Dogan, MD, Sedat Gurkok

Thomas S. Maxey, MD, Christopher D. Smith, MBBS, John A

Pediatric open heart operations without diagnostic cardiac catheterization Jean-Pierre Pfammatter, MD, Pascal A Berdat, MD, Thierry P Carrel, MD, Franco.

Is the second internal thoracic artery better than the radial artery in total arterial off- pump coronary artery bypass grafting? A propensity score–matched.

Support Your Specialty

Repair of aortic coarctation in patients more than 50 years of age

Traumatic tricuspid valve regurgitation and cerebral emboli

Morbidity, cost, and six-month outcome of minimally invasive direct coronary artery bypass grafting James A Magovern, MD, Daniel H Benckart, MD, Rodney.

Cardiac Operations in Patients 90 Years of Age and Older

Michel Carrier, MD, Michel Pellerin, MD, Louis P Perrault, MD, PhD, B

Results of valve replacement with omniscience mechanical prostheses

Editorial Board, January 2010

Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion James Tibballs, MD, Rodrigo Soto, MD, Tara Bharucha,

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Predictors and Outcomes of Seizures After Cardiac Surgery: A Multivariable Analysis of 2,578 Patients Andrew B. Goldstone, BA, David J. Bronster, MD,

Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease Ronald W Day, MD, John A Hawkins, MD, Edwin C McGough,

Is there a role for pneumonectomy in pulmonary metastases?1

Very Prolonged Stay in the Intensive Care Unit After Cardiac Operations: Early Results and Late Survival Shuli Silberman, MD, Daniel Bitran, MD, Daniel.

Inhaled nitric oxide for adult respiratory distress syndrome after pulmonary resection Douglas J Mathisen, MD, Elbert Y Kuo, Chiwon Hahn, MD, Ashby C.

Aortobronchial fistula after coarctation repair

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Massimo Meco, MD, Silvia Cirri, MD The Annals of Thoracic Surgery

Qing-yu Wu, MD The Annals of Thoracic Surgery

Neal S Goldstein, MD The Annals of Thoracic Surgery

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

“The more things change…”: The challenges ahead

Predictive factors for mortality and cerebral complications in arteriosclerotic aneurysm of the aortic arch Yutaka Okita, MD, Motomi Ando, MD, Kenji.

Postoperative cardiac tamponade in the modern surgical era

Commentary: Just say NO

The use of routine chest x-ray films after chest tube removal in postoperative cardiac patients James T McCormick, DO, Michael S O’Mara, MD, Pavlos K.

Factors influencing intensive care unit length of stay after surgery for acute aortic dissection type A Daniel Hoefer, MD, Elfriede Ruttmann, MD, Markus.

Adnan Cobanoglu, MD, Jess M Schultz, MD The Annals of Thoracic Surgery

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

The Impact of New Technology on Cardiothoracic Surgical Practice

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

How do we follow up our patients

Robert J Frumento, MS, MPH, Catherine M

Preoperative immunoglobulin treatment in patients with Werlhof’s disease undergoing cardiac operation Stefan Christiansen, MD, Christof Schmid, MD, Klaus.

Safety of low hematocrits during cardiopulmonary bypass

Vasoplegic syndrome: A new dilemma

Direct repair of giant right coronary aneurysm

Presentation transcript:

Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery Ricardo L Levin, MD, Marcela A Degrange, MD, Gustavo F Bruno, MD, Carlos D Del Mazo, MD, Daniel J Taborda, MD, Jorge J Griotti, MD, Fernando J Boullon, MD The Annals of Thoracic Surgery Volume 77, Issue 2, Pages 496-499 (February 2004) DOI: 10.1016/S0003-4975(03)01510-8

Fig 1 Evolution of vasoplegic patients. (MB = methylene blue; VS = vasoplegic syndrome.) The Annals of Thoracic Surgery 2004 77, 496-499DOI: (10.1016/S0003-4975(03)01510-8)

Fig 2 Number of vasoplegic patients with vasopressor requirements. (MB = methylene blue.) The Annals of Thoracic Surgery 2004 77, 496-499DOI: (10.1016/S0003-4975(03)01510-8)

Fig 3 Therapeutic options in postoperative vasoplegia. (NO = nitric oxide.) The Annals of Thoracic Surgery 2004 77, 496-499DOI: (10.1016/S0003-4975(03)01510-8)